Strategies for optimizing pathologic staging of sentinel lymph nodes in breast cancer patients

Virchows Archiv

Volumn 453, Issue 1, 2008, Pages 17-24

  Madsen, Eva V E ^a   Van Dalen, Jan ^b   Van Gorp, Joost ^a   Borel Rinkes, Inne H M ^c   Van Dalen, Thijs ^a  

^a DEPARTMENT OF SURGERY   (Netherlands)

^b ERASMUS UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Breast cancer; Micrometastases; Pathology; Sentinel lymph node; Staging

Indexed keywords

ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MATHEMATICAL MODEL; MICROMETASTASIS; NETHERLANDS; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

BREAST NEOPLASMS; FEMALE; GUIDELINES AS TOPIC; HUMANS; LYMPHATIC METASTASIS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NEOPLASM STAGING; NETHERLANDS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 48349109108     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-008-0601-1     Document Type: Article

References (30)

1. Attiyeh FF, Jensen M, Huvos AG, Fracchia A (1977) Axillary micrometastasis and macrometastasis in carcinoma of the breast. Surg Gynecol Obstet 144:839-842
2. Bolster MJ, Bult P, Schapers RF, Meijer JW, Strobbe LJ, van Berlo CL, Klinkenbijl JH, Peer PG, Wobbes T, Tjan-Heijnen VC (2006) Differences in sentinel lymph node pathology protocols lead to differences in surgical strategy in breast cancer patients. Ann Surg Oncol 13:1466-1473
3. CBO-richtlijn mammacarcinoom (2004) Nederlandse Vereniging voor Pathologie. http://www.pathology.nl. Cited Apr 2004
4. Colleoni M, Rotmensz N, Peruzzotti G, Maisonneuve P, Mazzarol G, Pruneri G, Luini A, Intra M, Veronesi P, Galimberti V, Torrisi R, Cardillo A, Goldhirsch A, Viale G (2005) Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol 23(7):1379-1389
5. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lyman GH, Berman C, Haddad F, Reintgen DS (1998) Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227:645-651
6. Cserni G, Gregori D, Merletti F, Sapino A, Mano MP, Ponti A, Sandrucci S, Baltas B, Bussolati G (2004) Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 91:1245-1252
7. Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Borisch B, Connolly CE, Decker T, Dervan P, Drijkoningen M, Ellis IO, Elston CW, Eusebi V, Faverly D, Heikkila P, Holland R, Kerner H, Kulka J, Jacquemier J, Lacerda M, Martinez-Penuela J, De Miguel C, Peterse JL, Rank F, Regitnig P, Reiner A, Sapino A, Sigal-Zafrani B, Tanous AM, Thorstenson S, Zozaya E, Fejes G, Wells CA (2004) Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol 57:695-701
8. Cserni G (2004) A model for determining the optimum histology of sentinel lymph nodes in breast cancer. J Clin Pathol 57:467-471
9. Cserni G (2002) Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol 55:926-931
10. Cserni G (2000) Mapping metastases in sentinel lymph nodes of breast cancer. Am J Clin Pathol 113:351-354
11. Farshid G, Pradhan M, Kollias J, Gill PG (2000) Computer simulations of lymph node metastasis for optimizing the pathologic examination of sentinel lymph nodes in patients with breast carcinoma. Cancer 89:2527-2537
12. Giuliano AE, Jones RC, Brennan M, Statman R (1997) Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15:2345-2350
13. Groen RS, Oosterhuis AWJ, Boers JE (2007) Pathologic examination of sentinel lymph nodes in breast cancer by a single haematoxylin-eosin slide versus serial sectioning and immunocytokeratin staining: clinical implications. Breast Cancer Res Treat 105:1-5
14. Huvos AG, Hutter RV, Berg JW (1971) Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 173:44-46
15. International (Ludwig) Breast Cancer Study Group (1990) Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 335:1565-1568
16. Krauth JS, Charitansky H, Isaac S, Bobin JY (2006) Clinical implications of axillary sentinel lymph node 'micrometastases' in breast cancer. Eur J Surg Oncol 32:400-404
17. Lyman GH, Giuliano AE, Somerfield MR, Benson AB III, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS III, Edge SB, Galper S, Hayman JA, Kim TY, Perkins CL, Podoloff DA, Sivasubramaniam VH, Turner RR, Wahl R, Weaver DL, Wolff AC, Winer EP (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703-7720
18. Maibenco DC, Dombi GW, Kau TY, Severson RK (2006) Significance of micrometastases on the survival of women with T1 breast cancer. Cancer 107:1234-1239
19. Meyer JS (1998) Sentinel lymph node biopsy: strategies for pathologic examination of the specimen. J Surg Oncol 69:212-218
20. Miltenburg DM, Miller C, Karamlou TB, Brunicardi FC (1999) Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 84:138-142
21. Richtlijn Behandeling van het mammacarcinoom (2004) Kwaliteitsinstituut voor de Gezondheidszorg CBO
22. van Rijk MC, Peterse JL, Nieweg OE, Oldenburg HS, Rutgers EJ, Kroon BB (2006) Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes. Cancer 107:467-471
23. Rosen PP, Saigo PE, Braun DW, Weathers E, Fracchia AA, Kinne DW (1981) Axillary micro- and macrometastases in breast cancer. Ann Surg 194:585-591
24. Sobin LH, Wittekind Ch (2002) TNM classification of malignant tumours, 6th edn. Wiley, Hoboken, New Jersey
25. Turner RR, Ollila DW, Krasne DL, Giuliano AE (1997) Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 226:271-276
26. Turner RR, Giuliano AE, Hoon DS, Glass EC, Krasne DL (2001) Pathologic examination of sentinel lymph node for breast carcinoma. World J Surg 25:798-805
27. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Maisonneuve P, Gatti G, Mazzarol G, De Cicco C, Manfredi G, Fernandez JR (2006) Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7:983-990
28. Viale G, Mastropasqua MG, Maiorano E, Mazzarol G (2006) Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: current and resolving controversies on the basis of the European Institute of Oncology experience. Virchows Arch 448:241-247
29. Viale G, Maiorano E, Mazzarol G, Zurrida S, Galimberti V, Luini A, Renne G, Pruneri G, Maisonneuve P, Veronesi U (2001) Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 92:1378-1384
30. Wilkinson EJ, Hause LL, Hoffman RG, Kuzma JF, Rothwell DJ, Donegan WL, Clowry LJ, Almagro UA, Choi H, Rimm AA (1982) Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases. Pathol Annu 17(Pt 2):67-91